Functional and Transcriptomic Recovery of Infarcted Mouse Myocardium Treated with Bone Marrow Mononuclear Cells
- 157 Downloads
Although bone marrow-derived mononuclear cells (BMNC) have been extensively used in cell therapy for cardiac diseases, little mechanistic information is available to support reports of their efficacy. To address this shortcoming, we compared structural and functional recovery and associated global gene expression profiles in post-ischaemic myocardium treated with BMNC transplantation. BMNC suspensions were injected into cardiac scar tissue 10 days after experimental myocardial infarction. Six weeks later, mice undergoing BMNC therapy were found to have normalized antibody repertoire and improved cardiac performance measured by ECG, treadmill exercise time and echocardiography. After functional testing, gene expression profiles in cardiac tissue were evaluated using high-density oligonucleotide arrays. Expression of more than 18% of the 11981 quantified unigenes was significantly altered in the infarcted hearts. BMNC therapy restored expression of 2099 (96.2%) of the genes that were altered by infarction but led to altered expression of 286 other genes, considered to be a side effect of the treatment. Transcriptional therapeutic efficacy, a metric calculated using a formula that incorporates both recovery and side effect of treatment, was 73%. In conclusion, our results confirm a beneficial role for bone marrow-derived cell therapy and provide new information on molecular mechanisms operating after BMNC transplantation on post ischemic heart failure in mice.
KeywordsHeart failure Microarray analysis Immune-inflammatory response Cardiac function
Disclosure of potential conflicts of interest
The authors indicate no potential conflicts of interest.
- 1.Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., et al. (2009). Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 119(3), 480–486.PubMedCrossRefGoogle Scholar
- 14.Mouquet, F., Pfister, O., Jain, M., Oikonomopoulos, A., Ngoy, S., Summer, R., et al. (2005). Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circulation Research, 97(11), 1090–1092.PubMedCrossRefGoogle Scholar
- 18.Lachtermacher, S., Esporcatte, B. L., Montalvao, F., Costa, P. C., Rodrigues, D. C., Belem, L., et al. (2010). Cardiac gene expression and systemic cytokine profile are complementary in a murine model of post-ischemic heart failure. Brazilian Journal of Medical and Biological Research, 43(4), 377–389.PubMedCrossRefGoogle Scholar
- 20.Ahn, D., Cheng, L., Moon, C., Spurgeon, H., Lakatta, E. G., & Talan, M. I. (2004). Induction of myocardial infarcts of a predictable size and location by branch pattern probability-assisted coronary ligation in C57BL/6 mice. American Journal of Physiology. Heart and Circulatory Physiology, 286(3), H1201–H1207.PubMedCrossRefGoogle Scholar
- 25.Barbash, I. M., Chouraqui, P., Baron, J., Feinberg, M. S., Etzion, S., Tessone, A., et al. (2003). Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation, 108(7), 863–868.PubMedCrossRefGoogle Scholar
- 33.Soares, M.B.P., Lima, R.S., Souza, B.S.F., Vasconcelos, J.F., Rocha, L.L., Ribeiro dos Santos, R., et al (2011). Reversion of gene expression alterations in hearts of mice with chronic chagasic cardiomyopathy after transplantation of bone marrow cells. Cell Cycle 10(9), 1448-1455Google Scholar
- 35.Soares, M. B. P., Lima, R. S., Rocha, L. L., Takyia, C. M., Pontes-de-Carvalho, L., de Carvalho, A. C. C., et al. (2004). Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice. The American Journal of Pathology, 164(2), 441–447.PubMedCrossRefGoogle Scholar